Gilead Sciences, Inc. (NASDAQ ... I'll now hand the call over to Jackie Ross, Vice President of Investor Relations and Corporate Strategic Finance. Jackie Ross : Thank you, Rebecca. Just after market ...

Presentation of Strong Preclinical Dataset: On September 25, 2024, HOOKIPA presented the preclinical proof-of-concept dataset ...

All presentations and supplemental materials will be available under the Investor Relations section of Aviat's website following the event. Gilead Sciences, Inc. announced today that its executives ...

Ligand Pharmaceuticals Incorporated today announced that Chief Executive Officer Todd Davis and Chief Financial Officer Tavo Espinoza will present at the Stifel 2024 Healthcare Conference in New York ...

Royalty Pharma inaugural Prize for Impact in Healthcare awarded to Michael Milken, the founder of the Milken Institute, Faster Cures & the ...

The late-breaking poster: Eseba-vec (HB-200) plus pembrolizumab as first-line treatment of recurrent/metastatic ...

Their study was part of a grant run out of the University of Alabama in partnership with UNC, the Vanderbilt University School of Medicine and pharmaceutical company Gilead Sciences ... senior vice ...

FOSTER CITY, Calif., November 08, 2024--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its ...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences: Jefferies London Healthcare ...

Despite a robust HIV portfolio and growing oncology sales, Gilead struggles to diversify revenue streams significantly. Learn ...